Lyophilization of a viral vaccine: Strategies for surrogate use in analytical characterization of cake properties and considerations on virus infectivity.

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42150651

Andrea Arsiccio; Andrea Hawe; Brecht Vanbillemont; Felix Reuter; Melanie Schwerdtfeger; Mona Atabakhshi Kashi; Sabine Ulamec; Tim Menzen; Wolfram Volkwein

May 19, 2026